Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

WHWK holding history

Whitehawk Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WHWK overviewAll 13F holders of WHWKFull Q4 2025 holdings

Shares (Q4 2025)
1,590,117
Value
$3.85M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of WHWK by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20251,590,117$3.85M<0.1%+247,210+18.4%AddedHolders
Q3 20251,342,907$2.55M<0.1%+27,622+2.1%AddedHolders
Q2 20251,315,285$2.46M<0.1%+549,293+71.7%AddedHolders
Q1 2025765,992$1.36M<0.1%00.0%UnchangedHolders
Q4 2024765,992$2.42M<0.1%00.0%UnchangedHolders
Q3 2024765,992$1.58M<0.1%00.0%UnchangedHolders
Q2 2024765,992$1.12M<0.1%−90,844−10.6%ReducedHolders
Q1 2024856,836$2.00M<0.1%−2,861−0.3%ReducedHolders
Q4 2023859,697$1.74M<0.1%+88,313+11.4%AddedHolders
Q3 2023771,384$3.73M<0.1%+9,480+1.2%AddedHolders
Q2 2023761,904$5.21M<0.1%−9,822−1.3%ReducedHolders
Q1 2023771,726$5.59M<0.1%+32,985+4.5%AddedHolders
Q4 2022738,741$9.48M<0.1%−2,428−0.3%ReducedHolders
Q3 2022741,169$10.5M<0.1%−92,658−11.1%ReducedHolders
Q2 2022833,827$10.3M<0.1%+73,544+9.7%AddedHolders
Q1 2022760,283$12.9M<0.1%−1,190−0.2%ReducedHolders
Q4 2021761,473$18.4M<0.1%+643,196+543.8%AddedHolders
Q3 2021118,277$3.47M<0.1%00.0%UnchangedConverted for a 1-for-15 splitHolders
Q2 20211,774,463$3.00M<0.1%+49,256+2.9%AddedHolders
Q1 20211,725,207$2.23M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.